Release Date: December 22, 2025
Expiration Date: December 22, 2026
Activity Overview
This session of the ISGIO 2025 meeting focused on the shifts in practice for patients with nonmetastatic colorectal cancer, including presentations focused on sparing the use of radiation therapy in patients with early-stage rectal cancer. Another program focused on nonmedical practices that can improve patient outcomes while undergoing treatment with curative intent. The session closed with a debate on the optimal use of immunotherapy for patients with operable colon cancer harboring high microsatellite instability.
Registration is also now open for ISGIO 2026, taking place October 2-3, 2026, in Ft Lauderdale, Florida. Click here to learn more.
Target Audience
This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in GI oncology. Other health care professionals interested in the treatment of these malignancies are also invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate the latest efficacy and safety data for newly approved agents, novel combinations, and novel agents to consider their potential impact on evolving treatment paradigms in GI cancers
- Develop personalized treatment plans for patients with GI cancers based on the latest evidence and practice guidelines
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here